Key result
A single-pill formulation combining different drugs may effectively manage patients with hypertension and hypercholesterolemia by improving treatment adherence.
Why the study?
Arterial hypertension and hypercholesterolemia increase cardiovascular risk, and early intervention to reduce both blood pressure and low-density lipoprotein cholesterol is important.
Early intervention with a single-pill formulation combining antihypertensive and lipid-lowering drugs may improve adherence and reduce cardiovascular risk.
Supports single-pill combinations for adherence in comorbid hypertension and hypercholesterolemia; leaves open outcome confirmation in randomized trials.
Arterial hypertension and hypercholesterolemia increase the risk of cardiovascular morbidity and mortality. Effectively reducing both blood pressure and circulating low-density lipoprotein cholesterol may considerably reduce cardiovascular risk. As this is particularly true if the intervention starts early, it is very important to identify and treat hypertension and hypercholesterolemia as early as possible. By improving adherence, a single-pill formulation that offers a combination of different drugs could be an effective way to manage patients with multiple cardiovascular risks.
No takes yet. Share an insight, caveat, or question.
Isabella Sudano (2022) conducted a review in Hypertension and hypercholesterolemia. Single-pill formulation was evaluated. A single-pill formulation combining different drugs may effectively manage patients with hypertension and hypercholesterolemia by improving treatment adherence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: